Hot Features
Registrieren Sie sich für Echtzeit-Benachrichtigungen, benutzerdefinierte Portfolios und Marktbewegungen.
Ligand Pharmaceuticals Inc is a biopharmaceutical company focused on developing and acquiring technologies that aid in creating medicine. The company has partnerships and license agreements with various pharmaceutical and biotechnology companies. Ligand's business model is based on drug discovery, e... Ligand Pharmaceuticals Inc is a biopharmaceutical company focused on developing and acquiring technologies that aid in creating medicine. The company has partnerships and license agreements with various pharmaceutical and biotechnology companies. Ligand's business model is based on drug discovery, early-stage drug development, product reformulation, and partnerships. The company's revenue consists of three primary elements: royalties from commercialized products, license and milestone payments, and sale of its trademarked Captisol material. Mehr anzeigen
Introduces 2025 full year revenue guidance of $180 million to $200 million, a 17% increase in revenue growth over 2024, and core adjusted earnings per diluted share of $6.00 to $6.25 Twelve...
Ligand Pharmaceuticals Incorporated (Nasdaq: LGND) today announced that Chief Executive Officer Todd Davis and Chief Financial Officer Tavo Espinoza will present at the Stifel 2024 Healthcare...
WAYNE, Pa., Oct. 17, 2024 (GLOBE NEWSWIRE) -- Palvella Therapeutics, Inc., a clinical-stage biopharmaceutical company focused on developing and commercializing novel therapies to treat patients...
| Zeitraum † | Änderung | Änderung % | Handelsbeginn | Hoch | Niedrig | Durchsch. Volumen | VWAP | |
|---|---|---|---|---|---|---|---|---|
| 1 | -2.87 | -2.56112796716 | 112.06 | 117.54 | 109.095 | 217932 | 114.37711896 | CS |
| 4 | -13.71 | -11.1554109032 | 122.9 | 127.86 | 109.095 | 130652 | 117.48849233 | CS |
| 12 | 5.54 | 5.34491075736 | 103.65 | 129.9 | 98.895 | 121636 | 115.50618855 | CS |
| 26 | 30.74 | 39.184193754 | 78.45 | 129.9 | 78.2 | 121008 | 106.922751 | CS |
| 52 | 36.21 | 49.616333242 | 72.98 | 129.9 | 67.53 | 134422 | 90.60836868 | CS |
| 156 | -51.84 | -32.1927591132 | 161.03 | 164.84 | 49.24 | 134362 | 85.32594266 | CS |
| 260 | 1.26 | 1.16742332994 | 107.93 | 219.75 | 49.24 | 210135 | 105.50080495 | CS |
Support: +44 (0) 203 8794 460 | support@advfn.de
Durch das Benutzen des ADVFN Angebotes akzeptieren Sie folgende Allgemeine Geschäftsbedingungen
Premium
